Organoids on the Market
Hubrecht Organoid Technology (HUB) and Crown Bioscience (JSR Corporation) became strategic partners to provide preclinical drug development and validation services.
“The partnership brings together HUB’s leading organoid technology platform and CrownBio’s global reach and preclinical service expertise to create an unparalleled translational platform to accelerate drug development and validation. HUB and CrownBio will establish a collaborative research program to accelerate further development of organoid technology. By opening a new site in Utrecht, Netherlands, CrownBio will help to cement Utrecht’s position as the global center of organoid technology research.”